The generic name of Simeglutide is Simeglutide Injection, and different manufacturers produce this product in different sizes, usually 1.34mg/ml in one bottle, 1.5ml or 3ml, i.e. one bottle has 2.01mg or 4.02mg. Simeglutide injection is mainly indicated for glycemic control in adults with type 2 diabetes mellitus, mainly in adults with type 2 diabetes mellitus who have poor glycemic control despite treatment with metformin or sulfonylureas. Common adverse reactions following injection of this product are gastrointestinal system disorders, including symptoms such as nausea, diarrhea, and vomiting. In addition, this product should not be used in the treatment of patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. It is contraindicated in pregnancy for those who are hypersensitive to the components of the product and to any of the excipients in the product. Before using Simeglutide Injection, you need to consult your doctor and follow the doctor’s instructions to avoid the adverse effects of self-injection.